Document is current
Any future updates will be listed below
-
Authors
Begg, Gordon A. http://orcid.org/0000-0001-5260-4293
Swoboda, Peter P.
Karim, Rashed
Oesterlein, Tobias
Rhode, Kawal
Holden, Arun V.
Greenwood, John P.
Shantsila, Eduard
Lip, Gregory Y. H.
Plein, Sven
Tayebjee, Muzahir H.
-
Funding
Funding for this research was provided by:
National Institute for Health Research
British Heart Foundation (FS/1062/28409)
Deutsche Forschungsgemeinschaft (DO637/14-1)
- License Information
-
More Information
Article History
Received: 11 March 2019
Accepted: 15 January 2020
First Online: 10 February 2020
Ethics approval and consent to participate
: The study was approved by the National Research Ethics Service (13/YH/0349). Written informed consent was obtained from all participants.
: Not applicable.
: St. Jude Medical supported Gordon Begg’s research fellowship. Gregory Lip has served as a consultant for Bayer/Jansen, BMS/Pfizer, Biotronik, Medtronic, Boehringer Ingelheim, Microlife, and Daiichi-Sankyo, and has been a speaker for Bayer/Jansen, BMS/Pfizer, Medtronic, Boehringer Ingelheim, Microlife, Roche and Daiichi-Sankyo. Muzahir Tayebjee has received research grants from St. Jude Medical, Medtronic, Biosense Webster, and Boehringher Ingelheim. Dr. Dana Peters served as the <i>JCMR</i> Guest Editor for this manuscript.
